Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ducray

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Neuro-Chirurgie|January 16, 2013
[Surgery of high-grade gliomas guided by fluorescence: a retrospective study of 22 patients]T Jacquesson, F Ducray, D Maucort-Boulch, et al.
Revue Neurologique|April 6, 2006
[Management of malignant gliomas diagnosed during pregnancy]F Ducray, P Colin, S Cartalat-Carel, et al.
Revue Neurologique|February 5, 2026
Early onset radiation-induced leukoencephalopathy in patients treated for a glioblastoma by STUPP protocol and risk factors evaluation, an ancillary study of the phase III ASTER protocolA Balcerac, S Cuzzubbo, F Bompaire, et al.
European Journal of Neurology|January 30, 2014
Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experienceF Ducray, G Demarquay, F Graus, et al.
Journal of Clinical Pharmacy and Therapeutics|January 11, 2016
Current trends in the management of glioblastoma in a French University Hospital and associated direct costsA M Henaine, N Paubel, F Ducray, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 25, 2013
Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patientsL Michel, S Vukusic, J De Seze, et al.
Journal of Clinical Pharmacy and Therapeutics|August 29, 2014
Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospitalG Diebold, F Ducray, A-M Henaine, et al.
Journal of Neuro-Oncology|November 17, 2017
Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kineticsC Izquierdo, A Alentorn, A Idbaih, et al.
Neurology|February 21, 2008
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebriG Kaloshi, S Everhard, F Laigle-Donadey, et al.
Journal of Neuro-Oncology|November 18, 2020
Characteristics of IDH-mutant gliomas with non-canonical IDH mutationL Poetsch, C Bronnimann, H Loiseau, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Neuro-Chirurgie|January 16, 2013
[Surgery of high-grade gliomas guided by fluorescence: a retrospective study of 22 patients]T Jacquesson, F Ducray, D Maucort-Boulch, et al.
Revue Neurologique|April 6, 2006
[Management of malignant gliomas diagnosed during pregnancy]F Ducray, P Colin, S Cartalat-Carel, et al.
Revue Neurologique|February 5, 2026
Early onset radiation-induced leukoencephalopathy in patients treated for a glioblastoma by STUPP protocol and risk factors evaluation, an ancillary study of the phase III ASTER protocolA Balcerac, S Cuzzubbo, F Bompaire, et al.
European Journal of Neurology|January 30, 2014
Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experienceF Ducray, G Demarquay, F Graus, et al.
Journal of Clinical Pharmacy and Therapeutics|January 11, 2016
Current trends in the management of glioblastoma in a French University Hospital and associated direct costsA M Henaine, N Paubel, F Ducray, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 25, 2013
Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patientsL Michel, S Vukusic, J De Seze, et al.
Journal of Clinical Pharmacy and Therapeutics|August 29, 2014
Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospitalG Diebold, F Ducray, A-M Henaine, et al.
Journal of Neuro-Oncology|November 17, 2017
Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kineticsC Izquierdo, A Alentorn, A Idbaih, et al.
Neurology|February 21, 2008
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebriG Kaloshi, S Everhard, F Laigle-Donadey, et al.
Journal of Neuro-Oncology|November 18, 2020
Characteristics of IDH-mutant gliomas with non-canonical IDH mutationL Poetsch, C Bronnimann, H Loiseau, et al.
Pageof 5